NDV Therapeutics Corporation
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
1. Research and development of novel stem cell drugs.
2. Research and development of novel immune cell drugs.
2. Research and development of novel immune cell drugs.
The content above was translated by Ai
Founded Year
2020
Unified Business No.
83093264
Status
Active
Number of Employees
0
Total Paid-in
Capital
60,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Chengzhi Biomedical is dedicated to the research and development of innovative cell technologies and product development and design. Looking ahead, the company hopes to obtain US FDA and Taiwan TFDA IND approvals in the shortest time possible, and after conducting Phase I/II clinical trials, secure conditional approval and official drug licenses from the Ministry of Health and Welfare to benefit patients.
The content above was translated by Ai
